University of Michigan Quantum Hamiltonian Model Infers a 14-Gene Regulatory Network From 127,000 Glioblastoma Cells: The arXiv 2602.19496 Revision of 1 October 2026

A quantum model of glioblastoma gene regulation

Quentir Medicine Monitor

Evidence-based insights for quantum medicine.

Glioblastoma is the most common primary malignant brain tumor in adults, and one reason it resists treatment is that its cells keep changing what they are. A single tumor holds cells that resemble astrocytes, neural progenitors, oligodendrocyte precursors and mesenchymal cells, and they can move between those states.

Four researchers at the University of Michigan have now tried to model that movement with the mathematics of quantum mechanics. In a paper first posted to arXiv on 23 February 2026 and revised on 1 October 2026, Mohammad Aamir Sohail, Ranga R. Sudharshan, S. Sandeep Pradhan and Arvind Rao describe a quantum Hamiltonian-based gene expression model, which they call QHGM, and an algorithm that learns its parameters from single-cell RNA sequencing data. They apply it to about 127,000 cells from glioblastoma patients and report a network of activating and repressing links among 14 genes.

For oncologists and genomics groups, the paper is worth reading for what it attempts and for how far it still is from the clinic. The model runs as a simulation on conventional graphics processors, its biological results have been compared with published literature and not yet with laboratory experiments, and its strongest benchmark numbers come from synthetic data that the model itself generated.

A gene regulatory network describes which genes switch other genes on or off. Single-cell RNA sequencing measures how strongly thousands of genes are expressed in each of many thousands of cells, and a family of computational methods tries to read the network back out of those measurements. The authors compare their approach with four established classical methods, ARACNE, GeneNet, GENIE3 and SINCERITIES.